Mark Kotter
@MarkKotter
Followers
874
Following
4
Media
5
Statuses
105
Clinician, scientist, entrepreneur #StemCellResearch, #CellReprogramming, #SpineSurgery, #MS CEO and founder https://t.co/BNSWptKi62
Cambridge, England
Joined August 2016
Exciting! This is the way…
AI is unlocking a thrilling era for discovery! @cziscience is training AI models to help scientists better understand cells and their structures. Our first projects will focus on genomic and biological data to better understand life at the molecular level.
0
0
5
How the world has evolved over the last century in terms of: - Child mortality - Life expectancy - GDP - Women's education - Basic water source - Basic sanitation [charts by @toddrjones] https://t.co/E0TM4L9pSP
83
570
2K
Minister @griffitha, thank you for shining a light on
bit.bio
With our opti-ox™ technology, we precisely, consistently, & efficiently reprogram stem cells into any cell type at scale for your research needs. Learn more!
NEWS! As @SciTechgovuk launch their £2 billion Vision for #EngineeringBiology, we hosted the Science Minister to officially open our new manufacturing and automation labs. Minister @griffitha toured our facilities + heard about our #cellprogramming tech:
0
0
2
NEWS! As @SciTechgovuk launch their £2 billion Vision for #EngineeringBiology, we hosted the Science Minister to officially open our new manufacturing and automation labs. Minister @griffitha toured our facilities + heard about our #cellprogramming tech:
bit.bio
Minister Griffith cut the ribbon to officially open bit.bio’s manufacturing and automation labs for the consistent and scalable production of human cells.
0
5
12
The more I think about the OpenAi mess, it is clearly one of the (probably The) greatest and most impactful corporate fuck-ups of the last 100 years and certainly the greatest fuck-up in not-for-profit history.
2
6
75
If you want to read up on rejuvenation biology and how https://t.co/ZPXKg4HBqQ fits in - here’s a link to the white paper: https://t.co/p3i0h2kXOw
mark-kotter.medium.com
“” is published by Mark Kotter.
1
2
11
Excited to announce the launch of https://t.co/ZPXKg4I9go and welcome @mwjgstoettner as its CEO. Thanks Ryan Cross at endpts for covering our story! https://t.co/c9OpMsWdrq.
endpoints.news
A small startup has raised $4 million to search for the source code of youthfulness by trawling through human DNA gene-by-gene to find factors that slow or speed the molecular ...
0
2
10
Excited to share that @bitbio has entered a collaboration with @BlueRockTx. We code human cells for novel cures, and in this partnership we will be creating regulatory T cells for use as therapies for complex autoimmune conditions. Find out more:
bit.bio
BlueRock Therapeutics and bit.bio announce collaboration and option agreement for the discovery & manufacture of regulatory T cell (Treg) based therapies.
0
1
14
Congratulations Nataly on the publication of you paper on #astrocyte networks! It suggest that astrocytes form a parallel mechanism of signal transmission in the brain that is separate from the neuronal connectome. I still have to digest the implications!
advanced.onlinelibrary.wiley.com
Astrocytes are brain cells that form large-scale networks; the role of astrocytic coupling in information processing is not well understood. The designed AstroMEA device shows that astrocytic...
0
4
8
📣 Feature! @Dlloydlevine writes about the promise of programmed #stemcells for #regenerativemedicine in @protolifemedia. Covering the data we presented @ISSCR + what leading researchers think is possible with our opti-ox tech. https://t.co/1dt5hpF8d7
#CellTherapy #drugdiscovery
proto.life
Bit.bio’s new approach for reprogramming pluripotent stem cells could standardize the reliable, large-scale manufacture of cells for research and therapy.
0
6
11
Juan Carlos Izpisua Belmonte’s presentation on anti-aging technology drew a dangerously large crowd at a stem cell conference in Boston.
technologyreview.com
Juan Carlos Izpisua Belmonte’s presentation on anti-aging technology drew a dangerously large crowd at a stem-cell conference in Boston.
5
9
39
BIG NEWS! We launched our new Custom ioDisease Model Cell offering! Scientists can order their mutation of choice to be genetically engineered in our consistent and defined opti-ox™️ powered human iPSC-derived cells. https://t.co/BFq0aPBTgF
#research #DrugDiscovery #iPSC
0
1
3
I can’t wait to see everyone in Oakland in 19 days for @SynBioBeta! We’re taking on human health in a big way - with lots of great talks and partnering activity to look forward to. It is one of my favorite community meetings of the year.
1
1
10
Cellular identity - what makes a cell a particular cell type. To me one of biology’s most fascinating mysteries. Here’s some data concerning astrocytes - a mystery cell type in the human brain. Kudos to the team! https://t.co/dx2BPLuapz
onlinelibrary.wiley.com
Four transcription factor combinations were used to program human iPSCs into iAstrocytes and differences were investigated Fine-tuning of the TF combination could produce iAs with greater therapeut...
1
0
6
Functional neurological restoration of amputated peripheral nerve using biohybrid regenerative bioelectronics https://t.co/gItTBNMIjg
@rochford_amy @AlejCarnicer @amy_jint @KawanMalak @Vin_Curto @AlexandraLRutz @baronedg @Cambridge_Eng
science.org
Implanted human iPSC-derived myocytes with flexible electronics on peripheral nerves allow enhanced electrophysiology recording.
3
14
95
Groundbreaking technology demonstrating restoration of an amputated peripheral nerve via integration of @bitbio ioMyocytes in a biohybrid bioelectric device. Congratulations @baronedg and @GeorgeMalliaras! https://t.co/1HEbS62BMh
3
4
13
After speaking with the UK's P&SC last month alongside influential members of the #Synbio sector. I have developed this blog outlining my recommendations for how the UK could grow to becomes a powerhouse of #science & #innovation in #syntheticbiology. https://t.co/f5Jdt6oDY5
mark-kotter.medium.com
At the end of 2022, I wrote about the opportunity for UK biotech to contribute to the UK’s economic growth agenda and the bright future…
0
0
1
Constructive discussions had with the P&SC on the opportunity for the UK to be a leader in #synbio of human health. Great to share @bitbio’s story as we work to ensure synbio is at the centre of the UK’s #ScienceSuperpower ambitions. Many thanks to @Metcalfe_SBET for chairing.
0
1
4
Lucky to have such a supportive industry body in the @BIA_UK. I would highly recommend reading #BIAFinanceReport: https://t.co/wCSJmWdDNX We continue to have very positive funding discussions, very excited to see what 2023 brings.
2
0
3